South African billionaire Stephen Saad loses more than $250 million from Aspen Pharma stake
Saad owns a 12.5-percent stake in Aspen Pharmacare Holdings, worth $566 million.
Stephen Saad
South African billionaire Stephen Saad’s Aspen could cut COVID-19 vaccine capacity
Saad controls a 12.5-percent stake in the leading drug company.
South African billionaire Stephen Saad’s Aspen concludes COVID-19 vaccine deal
The vaccine will be marketed as Aspenovax.
South African tycoon Stephen Saad’s Aspen partners with Siemens to boost vaccine production for Africa
The collaboration will enable Africa’s largest drugmaker to increase its production capacity to meet the rising vaccine demand in Africa.
Pharma tycoon Stephen Saad gains $38 million as Aspen moves to produce COVID-19 vaccines
The gains came in under 24 hours, as investors positively assessed his pharma company’s deal with J&J.
South African tycoon Stephen Saad’s Aspen Pharmacare signs J&J deal to sell COVID-19 vaccine in Africa
Aspen Pharmacare is a South African holding founded by pharma tycoon and billionaire businessman Stephen Saad.
South African billionaire Stephen Saad receives $1.6-million salary package from Aspen
The figure includes a performance bonus of $777,400 and remuneration of $555,433.
Pharma tycoon Stephen Saad’s Aspen sells six product lines to Swiss pharmaceutical company
Aspen is a multinational holding for pharmaceutical interests and the largest drug company in Africa.
South African pharma tycoon Stephen Saad seeks license for J&J COVID-19 vaccine
His company, Aspen Pharmacare, is a multinational South African holding.
Founder of Africa’s largest pharma company Stephen Saad earns $94.68 million in 38 days
Shares in his Aspen Pharmacare Holdings are surging to record highs.
Stephen Saad’s stake loses $29.31 million as Aspen shares retreat from two-year high
Shares in Aspen Pharmacare have been on a downward trend recently.
Global lenders team up with Stephen Saad’s Aspen on $711-million COVID-19 vaccine deal
The consortium hopes to help Africa avoid continued hoarding of COVID-19 vaccines by developed countries.
South African billionaire Stephen Saad’s stake in Aspen Pharmacare gains $168.9 million
Aspen is a global multinational pharmaceutical company.